Maximizing The Value Of Your AAV Using Small Volume AAV Testing

Analyzing recombinant Adeno-Associated Virus (rAAV) can be challenging, as significant portions of process development and clinical trial material batches are consumed during the measurement of critical quality attributes (CQAs). However, measuring specific rAAV CQAs, such as identity and purity, is a crucial part of gaining process understanding, developing control strategies, and mitigating the risks associated with AAV drug programs.

Learn about MilliporeSigma's approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run. This small-volume AAV testing package reduces the amount of test material required, so you can treat more patients.